Cargando…

Missing ligand model in autologous stem cell transplantation

Detalles Bibliográficos
Autores principales:	Stern, M, Paulussen, M, Rischewski, J, Tichelli, A, Gratwohl, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259173/ https://www.ncbi.nlm.nih.gov/pubmed/18087275 http://dx.doi.org/10.1038/sj.bjc.6604153

Ejemplares similares

Reply: Missing ligand model in autologous stem cell transplantation
por: Leung, W, et al.
Publicado: (2008)

Autologous stem cell transplantation in an older adult population
por: Fedorov, Kateryna, et al.
Publicado: (2022)

A Case with Hypothyrodism Following Autologous Stem Cell Transplantation
por: Bozkurt Duman, Berna, et al.
Publicado: (2013)

Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma
por: Srour, Samer A., et al.
Publicado: (2021)

Autologous hematopoietic stem cell transplantation with concomitant SARS-CoV-2 infection
por: Knaus, Hanna A., et al.
Publicado: (2021)

Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma
por: Sabulski, Anthony, et al.
Publicado: (2023)

Second autologous haematopoietic stem cell transplantation in systemic sclerosis—a case report
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2019)

Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis
por: Huh, Jin-Young, et al.
Publicado: (2017)

Unexpected debris after post thawing donor stem cells in autologous transplantation
por: Aksoy, Basak Adaklı, et al.
Publicado: (2021)

Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
por: Yuan, Yuan, et al.
Publicado: (2009)

Treatment pathways and resource use associated with recurrent Hodgkin lymphoma after autologous stem cell transplantation
por: Radford, J, et al.
Publicado: (2017)

Is There an Optimal Timing of Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Agents?
por: Toprak, Selami Koçak
Publicado: (2013)

Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation
por: Choi, Sue In, et al.
Publicado: (2016)

Real-word data on autologous stem cell transplantation in older patients with multiple myeloma
por: Schain, Frida, et al.
Publicado: (2019)

Leukaemia stem cells: hit or miss?
por: Glauche, I, et al.
Publicado: (2007)

COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease
por: Alsuliman, Tamim, et al.
Publicado: (2022)

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma
por: Aoki, T, et al.
Publicado: (2015)

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Accidental Overdose of Multiple Chemotherapeutic Agents
por: Kim, In Soon, et al.
Publicado: (1989)

Therapy-related Myelodysplastic Syndrome after Autologous Stem Cell Transplantation Using Plerixafor for Mobilized Stem Cells in a Patient with Multiple Myeloma
por: Tanaka, Hiroaki, et al.
Publicado: (2018)

Emergence of chronic myeloid leukemia following autologous stem cell transplantation in a young woman with multiple myeloma
por: Barrett, Aisling, et al.
Publicado: (2018)

Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant
por: Issaragrisil, S, et al.
Publicado: (2017)

Impact of labile plasma iron and iron chelation on the viability of cultured mononuclear cells from patients undergoing autologous hematopoietic stem cell transplantation
por: Naoum, Flávio Augusto, et al.
Publicado: (2017)

Letter: Safety and Feasibility of Autologous Mesenchymal Stem Cell Transplantation in Chronic Stroke in Indian patients. A four-year follow up
por: Davis, Oliver
Publicado: (2018)

B-cell-guided strategy for SARS-CoV2 vaccination after autologous stem cell transplantation for B-cell lymphoma — a case report
por: Baermann, Ben-Niklas, et al.
Publicado: (2022)

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
por: Marouf, Amira, et al.
Publicado: (2021)

Autologous Adipose Stem Cell Therapy for Autonomic Nervous System Dysfunction in Two Young Patients
por: Numan, Mohammed T., et al.
Publicado: (2017)

Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenström’s Macroglobulinemia
por: Kopińska, Anna J., et al.
Publicado: (2017)

Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma
por: Rashidi, A, et al.
Publicado: (2015)

Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase
por: Awada, Hussein, et al.
Publicado: (2023)

Celiac disease presented after autologous bone marrow transplantation for acute myelogenous leukemia
por: Valizadeh, Nasim, et al.
Publicado: (2013)

Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies
por: Kojima, Seiji, et al.
Publicado: (2014)

Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit
por: Mei, Matthew, et al.
Publicado: (2022)

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk
por: Corre, Jill, et al.
Publicado: (2020)

A Case of Preleukemic Chronic Myeloid Leukemia Following Chemotherapy and Autologous Transplantation for T-lymphoblastic Lymphoma
por: Choi, Hyunji, et al.
Publicado: (2020)

Successful implantation of autologous muscle-derived stem cells in treatment of faecal incontinence due to external sphincter rupture
por: Michal, Romaniszyn, et al.
Publicado: (2013)

Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis
por: KIM, Namho, et al.
Publicado: (2021)

Iron Overload in Hematopoietic Stem Cell Transplantation
por: Yasri, Sora, et al.
Publicado: (2017)

Stem cell transplantation for hemoglobinopathy Vila Real
por: Hasenkamp, Justin, et al.
Publicado: (2020)

Divergent Autologous T Cell Responses to Leukaemic Dendritic Cells during Remission in Acute Promyelocytic Leukaemia
por: Westers, Theresia M., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_hefs50hdqa8frcklop336knb27